retatrutide approval 2025 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market. This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in weight loss trials, outperforming current Semaglutide vs Retatrutide

This phenomenon demands clinical awareness and a non-judgemental approach to foster trust, openness, and engagement in clinical care

Changes in health-related quality of life and associations with improvements in clinical efficacy: a phase 2 study of mirikizumab in patients with ulcerative colitis

Alpha lipoic acid is a glutathione replenishing disulfide that increases whole blood and intracellular GSH levels

Its well-characterized pharmacological profile has established 5-Amino-1MQ as a valuable research tool for studying NNMT enzyme biology, enzyme-inhibitor interactions, methylation pathway regulation, nicotinamide-associated metabolic networks, and structure-activity relationships involving NNMT-targeting compounds

How does social media impact adoption

This is a full-scale pharma battle